The UK government is to launch a new industrial strategy aimed at helping the country thrive post-Brexit, and life sciences will be ‘centre stage’ when it is unveiled in the spring.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.